3652 results for «291»
3652 results
Is image fusion needed or too complex for standard transcatheter edge-to-edge repair?
21 Nov 2021 – From PCR London Valves 2021
Join Covadonga Fernandez-Golfin, Roberto Corti and Patric Biaggi if you want to learn about the benefits of image fusion and discover some tips and tricks on how to make image fusion easy and not complex in transcatheter edge-to-edge-repair.
Coronary artery access and revascularisation after TAVI
21 Nov 2021 – From PCR London Valves 2021
Find out more about coronary access post-TAVI in this PCR London Valves 2021 session, witness a coronary intervention after self-expanding TAVI or SAVR in low-risk patients, and review two-year outcomes following TAVI or SAVR in patients stratified by need for revascularisation, among others!
Pacemaker implantation after TAVI
21 Nov 2021 – From PCR London Valves 2021
Through this series of videos from PCR London Valves 2021, learn about the early outcomes of using the novel frame alignment technique during TAVI to improve pacemaker rates, see how cusp overlap projection reduces the burden of permanent pacemaker implantation after TAVR, appreciate the clinical utility of...
TAVI in bicuspid aortic valves
21 Nov 2021 – From PCR London Valves 2021
Thanks to this series of videos from PCR London Valves 2021, analyze the results of self-expandable versus balloon-expandable transcatheter valves in bicuspid aortic anatomy, study the outcomes after TAVI in bicuspid aortic valve, and much more!
Cases on miscellaneous coronary interventions
15 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover a selection of cases on miscellaneous coronary interventions unveiled at GulfPCR-GIM 2021: imaging-guided multivessel PCI in left main with TVD with rotablation in a ESRD, tiger catheter-induced left main occlusion, using IVL instead of rotational atherectomy, PCI of LIMA-LAD at anastomotic site in single surviving artery, aortocoronary dissection...
Cases on STEMI
15 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover a selection of STEMI cases presented at GulfPCR-GIM 2021, and learn more about: the treatment of intramural haematoma and AMI, the role of plaque modifying device in ACS, the therapeutic strategy for a pan-coronary vulnerability, the importance of stent visualisation to improve...
A mix of cases: HBR in ACS, endovascular venoplasty, carotid artery stenting and TAVI complications
Watch this session to discover various challenging cases presented at GulfPCR-GIM 2021: managing high-bleeding risk in ACS, endovascular venoplasty and stenting of subclavian vein in a patient on prolonged haemodialysis, flow arrest and reversal for carotid artery stenting in patients with high-grade bilateral stenosis, as well as TAVI complications...
Cases on CTO
16 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover 3 CTO cases unveiled at GulfPCR-GIM 2021: a successful CTO left circumflex PCI with periprocedural cardiac tamponade, a dynamic coronary roadmap as a guidance tool in CTO LAD recanalisation, as well as a complicated CTO to right coronary artery.
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)
07 Nov 2024
Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.
Author
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
